Skip to main content

Advertisement

Table 6 Difference in means between treatment and control groups for LDL at final follow-up

From: Screening for thyroid dysfunction and treatment of screen-detected thyroid dysfunction in asymptomatic, community-dwelling adults: a systematic review

Author Sample size (treatment group vs. control group) Difference 95% CI
Cabral et al. [57] 32 (14 vs. 18) − 0.99 mmol/L* − 2.40 to 0.42
Caraccio et al. [58] 49 (24 vs. 25) − 0.30 mmol/L* − 0.83 to 0.23
Duman et al. [60] 39 (20 vs. 19) 0.11 mmol/L* − 0.89 to 1.11
Iqbal et al. [62] 64 (32 vs. 32) 0.00 mmol/L* − 0.47 to 0.47
Liu et al. [64] 119 (60 vs. 59) − 0.12 mmol/L** − 0.32 to 0.08
Mikhail et al. [66] 120 (60 vs. 60) − 0.21 mmol/L* − 0.46 to 0.03
Monzani et al. [68] 45 (23 vs. 22) − 1.23 mmol/L* − 2.32 to − 0.13
Nagasaki et al. [69] 95 (48 vs. 47) − 0.22 mmol/L** − 0.70 to 0.26
Teixeira et al. [74, 75] 26 (11 vs. 15) − 0.63 mmol/L* − 1.90 to 0.64
  1. *Value is the difference in mean scores at final follow-up between treatment and control groups
  2. **Value is the difference in mean variation scores from baseline to follow-up between treatment and control group